Leipzig, Germany, 25th March 2025 – c-LEcta, a leading international supplier of enzymes for the biopharmaceutical industry, proudly announces the.

After submitting a GRAS notification for NuCLEANase (GRN No.1146) to the US FDA, c-LEcta has received a positive evaluation with no questions from.